Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.745 USD | -0.29% | +17.33% | +211.50% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+211.50% | 321M | |
+29.82% | 682B | |
+30.35% | 586B | |
-3.76% | 364B | |
+17.73% | 327B | |
+3.10% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.38% | 165B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Nektar Therapeutics to Cut Staff, Reprioritize Projects in Cost Cutting Plan